Research Article
Tumor Primary Location May Affect Metastasis Pattern for Patients with Stage IV NSCLC: A Population-Based Study
Table 2
Multivariate logistic regression analyses to evaluate the risk factors for different metastasis patterns.
| Variables | Bone metastasis | Brain metastasis | Liver metastasis | Lung metastasis | OR (95% CI) | P | OR (95% CI) | | OR (95% CI) | P | OR (95% CI) | |
| Age | | <0.001 | | <0.001 | | 0.060 | | <0.001 | <65 | Reference | ≥65 | 0.860 (0.810–0.914) | <0.001 | 0.581 (0.544–0.621) | <0.001 | 0.927 (0.857–1.003) | 0.060 | 1.222 (1.143–1.307) | <0.001 |
| Race | | <0.001 | | 0.088 | | 0.239 | | <0.001 | White | Reference | Black | 0.834 (0.764–0.911) | <0.001 | 0.911 (0.827–1.003) | 0.057 | 0.913 (0.814–1.023) | 0.116 | 1.011 (0.920–1.112) | 0.817 | Others | 0.991 (0.893–1.101) | 0.871 | 1.051 (0.938–1.178) | 0.390 | 0.944 (0.821–1.085) | 0.415 | 1.277 (1.141–1.429) | <0.001 |
| Sex | | <0.001 | | <0.001 | | 0.064 | | 0.028 | Female | Reference | Male | 1.188 (1.119–1.261) | <0.001 | 0.886 (0.829–0.946) | <0.001 | 1.077 (0.996–1.164) | 0.064 | 0.929 (0.870–0.992) | 0.028 |
| Histology | | <0.001 | | <0.001 | | 0.794 | | <0.001 | Adenocarcinoma | Reference | Squamous cell carcinoma | 0.663 (0.619–0.709) | <0.001 | 0.501 (0.461–0.543) | <0.001 | 1.012 (0.928–1.103) | 0.794 | 0.849 (0.789–0.914) | <0.001 |
| T stage | | <0.001 | | <0.001 | | 0.206 | | <0.001 | T1 | Reference | T2 | 0.847 (0.765–0.937) | 0.001 | 0.980 (0.878–1.094) | 0.721 | 1.059 (0.921–1.219) | 0.421 | 1.408 (1.210–1.637) | <0.001 | T3 | 0.815 (0.734–0.904) | <0.001 | 0.843 (0.752–0.944) | 0.003 | 1.131 (0.982–1.303) | 0.088 | 4.400 (3.808–5.086) | <0.001 | T4 | 0.829 (0.750–0.917) | <0.001 | 0.794 (0.711–0.886) | <0.001 | 1.131 (0.986–1.297) | 0.079 | 6.967 (6.048–8.024) | <0.001 |
| N stage | | <0.001 | | <0.001 | | <0.001 | | <0.001 | N0 | Reference | N1 | 1.279 (1.135–1.440) | <0.001 | 1.194 (1.047–1.361) | 0.008 | 1.304 (1.110–1.532) | 0.001 | 0.915 (0.796–1.050) | 0.205 | N2 | 1.314 (1.219–1.417) | <0.001 | 1.172 (1.078–1.273) | <0.001 | 1.510 (1.362–1.673) | <0.001 | 1.120 (1.030–1.218) | 0.008 | N3 | 1.308 (1.195–1.432) | <0.001 | 1.031 (0.932–1.141) | 0.552 | 1.473 (1.304–1.664) | <0.001 | 1.654 (1.500–1.823) | <0.001 |
| Primary site | | 0.009 | | 0.003 | | 0.723 | | 0.008 | Main bronchus | Reference | Upper lobe | 1.141 (0.996–1.307) | 0.057 | 1.229 (1.052–1.437) | 0.010 | 0.939 (0.794–1.111) | 0.463 | 1.182 (1.022–1.367) | 0.024 | Middle lobe | 1.150 (0.956–1.384) | 0.139 | 1.219 (0.990–1.501) | 0.062 | 0.900 (0.709–1.141) | 0.384 | 1.242 (1.015–1.519) | 0.035 | Lower lobe | 1.222 (1.062–1.408) | 0.005 | 1.127 (0.958–1.326) | 0.149 | 0.948 (0.795–1.130) | 0.550 | 1.299 (1.116–1.512) | 0.001 | Overlapping lesion | 0.864 (0.639–1.169) | 0.342 | 0.814 (0.573–1.157) | 0.252 | 1.132 (0.792–1.618) | 0.495 | 1.139 (0.840–1.544) | 0.402 |
|
|